Arnfin B. Bergmann
Neuburg An Der Donau, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT).
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: February 24, 2026
Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry.
Journal: Neurology and therapy
Published: December 17, 2024
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments.
Journal: Journal of central nervous system disease
Published: December 05, 2023
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: March 27, 2023
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.
Journal: Multiple sclerosis and related disorders
Published: May 04, 2022
PHREND®-A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis.
Journal: Frontiers in digital health
Published: January 17, 2022
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.
Journal: International journal of MS care
Published: January 17, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 04, 2022
Implementation of a data control framework to ensure confidentiality, integrity, and availability of high-quality real-world data (RWD) in the NeuroTransData (NTD) registry.
Journal: JAMIA open
Published: December 22, 2021
How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?
Journal: Journal of central nervous system disease
Published: July 30, 2021
Last Updated: 09/26/2026